Scientists have developed a coffee machine-sized 3D bioprinter that produces human-like tissue in a move they hope could potentially speed up the development of new treatments for the likes of heart ...

The collaboration combines Salipro Biotech's unique expertise and its Salipro® platform technology to stabilise challenging drug targets from Boehringer Ingelheim's drug discovery programs to enable ...

Egypt is transforming into Africa's pharmaceutical powerhouse, with 90% of drugs now produced locally. Through strategic ...

The latest HPRA inspection in February 2025 was highly successful-both QC licences were renewed, and viral vector manufacturing was added to the MIA (IMP) licence. This means the Shannon site can ...

Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...

Arthur Caplan, PhD, is the Drs. William F. and Virginia Connolly Mitty Professor and founding head of the Division of Medical Ethics at NYU Grossman School of Medicine. Lisa Kearns, MS, MA, is a ...

The investment of over $6 million will expand LGM Pharma’s Rosenberg, Texas manufacturing facility as part of its Phase I ...

The estimated $80 million project is expected to bring affordable housing, a vocational training center, space for commercial ...

Carolyn Schutt Ibsen uses ultrasound to improve tumor targetingand tissue engineering from bioink to 3D models.

The system of finding, diagnosing and treating TB has collapsed in dozens of countries across Africa and Asia since President Trump ordered the aid freeze.

Preclinical drug evaluation, especially for cardiotoxicity, is a critical stage in the drug development process.

NanoViricides, Inc. (the “Company”)(NYSE American:NNVC), a clinical-stage global leader developing revolutionary broad-spectrum antiviral drugs that the viruses cannot escape, declared today that its ...